A new Haemostatic agent's effect on the success of calcium hydroxide pulpotomy in primary molars

Pediatric Dentistry

Volumn 33, Issue 7, 2011, Pages 529-534

  Odabas M E ^a   Cinar C ^a   Tulunoglu O ^a   Isik B ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Calcium Hydroxide; Haemostatic Agent; Pulpotomy

Indexed keywords

ANKAFERD BLOOD STOPPER; BIOMEDICAL AND DENTAL MATERIALS; CALCIUM HYDROXIDE; HEMOSTATIC AGENT; PLANT EXTRACT; SODIUM CHLORIDE;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COTTON; DECIDUOUS TOOTH; DENTAL CARIES; ENDODONTICS; FOLLOW UP; HUMAN; METHODOLOGY; MOLAR TOOTH; PATHOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

CALCIUM HYDROXIDE; COTTON FIBER; DENTAL CARIES; DENTAL PULP EXPOSURE; FOLLOW-UP STUDIES; HEMOSTATICS; HUMANS; MOLAR; PLANT EXTRACTS; PULP CAPPING AND PULPECTOMY AGENTS; PULPOTOMY; SODIUM CHLORIDE; TIME FACTORS; TOOTH, DECIDUOUS; TREATMENT OUTCOME;

EID: 83655193373     PISSN: 01641263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Fuks AB. Vital pulp therapy with new materials for primary teeth: New directions and treatment perspectives. J Endod 2008;34:S18-24.
2. Fuks AB. Current concepts in vital primary pulp therapy. Eur J Paediatr Dent 2002;3:115-20.
3. Hill SD, Berry CW, Seale NS, Kaga M. Comparison of antimicrobial and cytotoxic effects of glutaraldehyde and formocresol. Oral Surg Oral Med Oral Pathol 1991;71: 89-95.
4. Casas MJ, Kenny DJ, Judd PL, Johnston DH. Do we still need formocresol in pediatric dentistry? J Can Dent Assoc 2005;71:749-51. (Pubitemid 43001278)
5. Waterhouse PJ, Nunn JH, Whitworth JM. An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. Br Dent J 2000;188:32-6.
6. Huth KC, Paschos E, Hajek-Al-Khatar N, et al. Effectiveness of 4 pulpotomy techniques: Randomized controlled trial. J Dent Res 2005;84:1144-8. (Pubitemid 43827782)
7. Markovic D, Zivojinovic V, Vucetic M. Evaluation of three pulpotomy medicaments in primary teeth. Eur J Paediatr Dent 2005;6:133-8.
8. Magnusson B. Therapeutic pulpotomy in primary molars: Clinical and histological follow-up. I. Calcium hydroxide paste as wound dressing. Odontol Revy 1970;21:415-31.
9. Schroder U. A 2-year follow-up of primary molars, pulpotomized with a gentle technique and capped with calcium hydroxide. Scand J Dent Res 1978;86:273-8. (Pubitemid 9006888)
10. Percinoto C, de Castro AM, Pinto LM. Clinical and radiographic evaluation of pulpotomies employing calcium hydroxide and trioxide mineral aggregate. Gen Dent 2006; 54:258-61. (Pubitemid 44384497)
11. Alacam A, Odabas ME, Tuzuner T, Sillelioglu H, Baygin O. Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:e127-33.
12. Stanley HR. Pulp capping: Conserving the dental pulp - can it be done? Is it worth it? Oral Surg Oral Med Oral Pathol 1989;68:628-39. (Pubitemid 19278843)
13. Schroder U. Effect of an extra-pulpal blood clot on healing following experimental pulpotomy and capping with calcium hydroxide. Odontol Revy 1973;24:257-68.
14. Schroder U. Effects of calcium hydroxide-containing pulpcapping agents on pulp cell migration, proliferation, and differentiation. J Dent Res 1985;64(special issue):541-8.
15. Hebling J, Giro EM, Costa CA. Biocompatibility of an adhesive system applied to exposed human dental pulp. J Endod 1999;25:676-82.
16. Horsted P, El Attar K, Langeland K. Capping of monkey pulps with Dycal and a Ca-eugenol cement. Oral Surg Oral Med Oral Pathol 1981;52:531-53. (Pubitemid 12221760)
17. Kitasako Y, Inokoshi S, Fujitani M, Otsuki M, Tagami J. Short-term reaction of exposed monkey pulp beneath adhesive resins. Oper Dent 1998;23:308-17. (Pubitemid 128686558)
18. Fei AL, Udin RD, Johnson R. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatr Dent 1991;13:327-32.
19. Accorinte Mde L, Loguercio AD, Reis A, Muench A, de Araujo VC. Response of human pulp capped with a bonding agent after bleeding control with hemostatic agents. Oper Dent 2005;30:147-55. (Pubitemid 40521724)
20. Accorinte Mde L, Loguercio AD, Reis A, Holland R. Effects of hemostatic agents on the histomorphologic response of human dental pulp capped with calcium hydroxide. Quintessence Int 2007;38:843-52.
21. Hafez AA, Cox CF, Tarim B, Otsuki M, Akimoto N. An in vivo evaluation of hemorrhage control using sodium hypochlorite and direct capping with a one- or two-component adhesive system in exposed nonhuman primate pulps. Quintessence Int 2002;33:261-72.
22. Matsuda H, Ando S, Kato T, Morikawa T, Yoshikawa M. Inhibitors from the rhizomes of Alpinia officinarum on production of nitric oxide in lipopolysaccharide-activated macrophages and the structural requirements of diarylheptanoids for the activity. Bioorg Med Chem 2006;14:138-42. (Pubitemid 41635477)
23. Testai L, Chericoni S, Calderone V, et al. Cardiovascular effects of Urtica dioica L. (Urticaceae) roots extracts: In vitro and in vivo pharmacological studies. J Ethnopharmacol 2002;81:105-9. (Pubitemid 34518474)
24. Sheela ML, Ramakrishna MK, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol 2006;6:494-8. (Pubitemid 43120464)
25. Barka EA, Belarbi A, Hachet C, Nowak J, Audran JC. Enhancement of in vitro growth and resistance to gray mould of Vitis vinifera co-cultured with plant growth-promoting rhizobacteria. FEMS Microbiol Lett 2000;186:91-5. (Pubitemid 30211747)
26. Barka EA, Gognies S, Nowak J, Audran JC, Belarbi A. Inhibitory effect of endophyte bacteria on Botrytis cinerea and its influence to promote the grapevine growth. Biol Control 2002;24:135-42. (Pubitemid 34623280)
27. Goker H, Haznedaroglu IC, Ercetin S, et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008;36:163-70. (Pubitemid 351255983)
28. Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol 2010;267:1377-8.
29. Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol 2009;73:1742-5.
30. Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc 2010;71: 873-5.
31. Kurt M, Disibeyaz S, Akdogan M, Sasmaz N, Aksu S, Haznedaroglu IC. Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: A case report. Am J Gastro-enterol 2008;103:2156-8.
32. Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy 2008;40(suppl): E262.
33. Ibis M, Kurt M, Onal IK, Haznedaroglu IC. Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd blood stopper. J Altern Complement Med 2008;14:1073-4.
34. Aydin S. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2009;37:279.
35. Cipil HS, Kosar A, Kaya A, et al. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost 2009;15:270-6.
36. Thompson KS, Seale NS, Nunn ME, Huff G. Alternative method of hemorrhage control in full strength formocresol pulpotomy. Pediatr Dent 2001;23:217-22. (Pubitemid 33699340)
37. Primosch RE, Glomb TA, Jerrell RG. Primary tooth pulp therapy as taught in predoctoral pediatric dental programs in the United States. Pediatr Dent 1997;19:118-22. (Pubitemid 127735278)
38. Dunston B, Coll JA. A survey of primary tooth pulp therapy as taught in US dental schools and practiced by diplomates of the American Board Of Pediatric Dentistry. Pediatr Dent 2008;30:42-8.
39. Chaollai N, Monterio A, Duggal MS. A Survey of Primary Tooth Pulp Therapy Techniques Taught in Dental Schools in Ireland and the UK. 9th Congress of the EAPD Abstracts O11. Dubrovnik, Croati; 2008:59.
40. International Agency for Research on Cancer. World Health Organization. IARC classifies formaldehyde as carcinogenic to humans. Available at: "http://www.iarc.fr/ENG/Press- Releases/archives/pr153a.html". Accessed February 27, 2008.
41. Tunc ES, Saroglu I, Sari S, Gunhan O. The effect of sodium hypochlorite application on the success of calcium hydroxide pulpotomy in primary teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:e22-6. (Pubitemid 44109985)
42. Stanley HR. Criteria for standardizing and increasing credibility of direct pulp capping studies. Am J Dent 1998;11 (special issue):S17-34. (Pubitemid 128505160)
43. Ranly DM, Garcia-Godoy F. Current and potential pulp therapies for primary and young permanent teeth. J Dent 2000;28:153-61.
44. Lemon RR, Steele PJ, Jeansonne BG. Ferric sulfate hemostasis: Effect on osseous wound healing. Left in situ for maximum exposure. J Endod 1993;19:170-3.
45. Bilgili H, Kosar A, Kurt M, et al. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Med Princ Pract 2009;18:165-9.
46. Peng L, Ye L, Guo X, et al. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: A systematic review and meta-analysis. Int Endod J 2007;40:751-7.
47. Peng L, Ye L, Tan H, Zhou X. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: A meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:e40-4. (Pubitemid 44810056)
48. Loh A, O'Hoy P, Tran X, et al. Evidence-based assessment: Evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatr Dent 2004;26:401-9. (Pubitemid 41742741)
49. Schröder U. Pedodontic endodontics. In: Koch G, Poulsen S, eds. Pediatric Dentistry: A Clinical Approach. Oxford, UK: Blackwell Munksgaard; 2001:213-33.
50. Briso AL, Rahal V, Mestrener SR, Dezan Junior E. Biological response of pulps submitted to different capping materials. Braz Oral Res 2006;20:219-25. (Pubitemid 44613636)
51. Croll TP, Killian CM. Zinc oxide-eugenol pulpotomy and stainless steel crown restoration of a primary molar. Quintessence Int 1992;23:383-8.
52. Mejare I. Pulpotomy of primary molars with coronal or total pulpitis using formocresol technique. Scand J Dent Res 1979;87:208-16.
53. Hobson P. Pulp treatment of deciduous teeth. 2. Clinical investigation. Br Dent J 1970;128:275-82.
54. Moretti AB, Sakai VT, Oliveira TM, et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide, and formocresol for pulpotomies in primary teeth. Int Endod J 2008;41:547-55.
55. Holan G, Eidelman E, Fuks AB. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatr Dent 2005;27:129-36. (Pubitemid 43339749)
56. Maroto M, Barberia E, Planells P, Garcia Godoy F. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. Am J Dent 2005;18:151-4. (Pubitemid 41139533)
57. Smith NL, Seale NS, Nunn ME. Ferric sulfate pulpotomy in primary molars: A retrospective study. Pediatr Dent 2000;22:192-9.
58. Papagiannoulis L. Clinical studies on ferric sulphate as a pulpotomy medicament in primary teeth. Eur J Paediatr Dent 2002;3:126-32.
59. Kalaskar RR, Damle SG. Comparative evaluation of lyophilized freeze dried platelet derived preparation with calcium hydroxide as pulpotomy agents in primary molars. J Indian Soc Pedod Prev Dent 2004;22:24-9.
60. Cox CF, Subay RK, Ostro E, Suzuki S, Suzuki SH. Tunnel defects in dentin bridges: Their formation following direct pulp capping. Oper Dent 1996;21:4-11. (Pubitemid 126701676)
61. Waterhouse PJ, Nunn JH, Whitworth JM. Primary molar vital pulp theory. Br Dent J 2000;188:417.
62. Bilgili H, Captug O, Kosar A, et al. Oral systemic administration of Ankaferd Blood Stopper has no short-term toxicity in an in vivo rabbit experimental model. Clin Appl Thromb Hemost 2010;16:533-6.